<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">CRCM</journal-id><journal-title-group><journal-title>Case Reports in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2325-7075</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/crcm.2023.128038</article-id><article-id pub-id-type="publisher-id">CRCM-126778</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Neuro-meningeal Tuberculosis in Adult Senegalese Patients: Profile and Outcome of Cases Diagnosed at a Referral Service, from 2015 to 2020
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Daouda</surname><given-names>Thioub</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Viviane</surname><given-names>Marie Pierre Cisse-Diallo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>apa</surname><given-names>Latyr Junior Diouf</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ndeye</surname><given-names>Aissatou Lakhe</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Agbogbenkou</surname><given-names>TeviDéla-dem Lawson</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aboubakar</surname><given-names>Sidikh Badiane</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ndeye</surname><given-names>Maguette Fall</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Khardiata</surname><given-names>Diallo-Mbaye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Daye</surname><given-names>Ka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sylvie</surname><given-names>Audrey Diop</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Moussa</surname><given-names>Seydi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Infectious and Tropical Diseases Department of Fann National University Hospital, Dakar, Senegal</addr-line></aff><aff id="aff2"><addr-line>Health Sciences Training and Research Unit, Iba Der Thiam University, Thiès, Senegal</addr-line></aff><pub-date pub-type="epub"><day>01</day><month>08</month><year>2023</year></pub-date><volume>12</volume><issue>08</issue><fpage>270</fpage><lpage>278</lpage><history><date date-type="received"><day>21,</day>	<month>June</month>	<year>2023</year></date><date date-type="rev-recd"><day>31,</day>	<month>July</month>	<year>2023</year>	</date><date date-type="accepted"><day>2,</day>	<month>August</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Among patients treated for tuberculosis, 2% to 5% have a Central Nervous System (CNS) lesion, and its frequency rises to 10% in HIV-infected patients. Neuro-meningeal tuberculosis (NMT) is responsible for death and severe permanent neurological damage. This poor prognosis requires early diagnosis and rapid initiation of specific treatment. Unfortunately, the great clinical polymorphism and the lack of specificity of radiological and biological signs are frequently responsible for a delay in diagnosis and management. Senegal is one of the African countries where tuberculosis has remained a concern until now. And there are no studies carried out on this subject. 
  Objective: The objective of this study was to describe the profile and outcome of Neuro-meningeal tuberculosis (NMT) cases diagnosed at the infectious diseases department (SMIT) of Fann University Hospital in Dakar, (referral service for management of tuberculosis). 
  Methods: We carried out a retrospective, descriptive and analytical study, reviewing medical records of adults diagnosed with NMT at the SMIT of Fann Hospital from January 2015 to December 2020. 
  Results: We collected 55 cases of NMT. The median age was 38 years [range 16 - 77 years]. The sex ratio (M/F) was 3.23. HIV patients represented 41.82% of cases. A history of tuberculosis was found in 25.5% of cases. The delay in consultation was greater than one month in 60% of patients. Headaches were the most constant reason for consultation (94.55%). Meningeal signs were present in 94.55% of patients, and consciousness disorders and intracranial hypertension were present in 63.64% and 56.36% respectively. Nerve palsy was found in 38.18%. CSF was clear in 81.64%. GeneXpert MTB/RIF in CSF was performed in 33 patients and was positive in 4 patients. Brain CT was abnormal in 72.09% of cases. Tuberculoma, hydrocephalus and meningeal contrast enhancement were the main lesions. The neuro-meningeal localization was associated with a pulmonary form in 32.7%. The lethality rate was 21.8%; higher in women (46.2% vs 14.3%; p = 0.01), in patients with a delay in consultation &gt; 1 month (p = 0.03), and in patients who presented with consciousness disorders (p = 0.007).
   Conclusion: Despite the availability of the GeneXpert MTB/RIF, diagnosis of NMT remains difficult. Because of its variable clinical expression and the low sensitivity of the GeneXpert MTB/rif in the CSF, it exposes patients to serious complications. Among the factors associated with death, we found consciousness disorders, a long delay in diagnosis.
 
</p></abstract><kwd-group><kwd>Neuro-meningeal</kwd><kwd> Outcome</kwd><kwd> Profile</kwd><kwd> Senegal</kwd><kwd> Tuberculosis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Tuberculosis is a major public health problem, especially in developing countries [<xref ref-type="bibr" rid="scirp.126778-ref1">1</xref>] . It is one of the top 10 causes of death worldwide [<xref ref-type="bibr" rid="scirp.126778-ref2">2</xref>] . Neuro-meningeal involvement is rare but represents one of the most severe forms with high morbidity and mortality. This localization represents 5% - 15% of extra pulmonary tuberculosis [<xref ref-type="bibr" rid="scirp.126778-ref3">3</xref>] . Among tuberculosis cases, 2% to 5% have a CNS lesion and its frequency rises to 10% in HIV-infected patients. The case fatality rate for untreated Neuro-meningeal tuberculosis (NMT) is almost 100% and delay in treatment often leads to permanent neurological damage in more than 50%, despite anti-tuberculosis treatment [<xref ref-type="bibr" rid="scirp.126778-ref4">4</xref>] . Prompt diagnosis is crucial for successful disease management. Unfortunately, the great clinical polymorphism and the lack of specificity of radiological and biological signs, apart from the identification of BK by the nucleic acid amplification test (GeneXpert MTB/RIF) in the cerebral spinal fluid (CSF), make diagnosis difficult and are frequently responsible for a delay in treatment [<xref ref-type="bibr" rid="scirp.126778-ref4">4</xref>] . Senegal is one of the African countries where tuberculosis has remained a concern until now. And there are no studies carried out on this subject. We undertook this study to describe the profile and the outcome of NMT cases diagnosed in the infectious diseases department (SMIT) of the Fann university hospital in Dakar from 2015 to 2020.</p></sec><sec id="s2"><title>2. Methods</title><p>We carried out a retrospective, descriptive and analytical study, reviewing medical records of adults diagnosed with neuro-meningeal tuberculosis at the SMIT of Fann Hospital from January 2015 to December 2020. The SMIT is in a region with a high incidence of tuberculosis in Senegal and serves a population of low socio-economic status in Dakar. Cases were identified by reviewing the database of the hospital’s Department of Epidemiology and the discharge registry of the infectious diseases department. We included all cases that met the case definition.</p><p>Our cases were defined on the presence of at least one of the following criteria:</p><p>• Positive GeneXpert MTB/rif in cerebrospinal fluid (CSF) or,</p><p>• Lymphocytic meningitis is associated with another confirmed TB site that has progressed well under antituberculosis treatment.</p><p>We excluded patients who had incomplete records, patients under 18 years of age and those who had a final diagnosis other than NMT.</p><p>We recorded demographic and clinical information, laboratory results, drug treatment and outcome at discharge from the clinical files and microbiology department records. CSF macroscopic examination, protein and glucose quantification and cell count were performed at the hospital laboratory. HIV status was determined using HIV 1 + 2 ELISA test with a confirmatory immunofluorescent assay.</p><p>Descriptive statistics were performed for clinical, epidemiological and laboratory features. The statistical analyses were performed with Epi info 7.2 and SPSS V 21. Bivariate analysis was used to look for associations between variables, using Chi2 and Fisher tests. The alpha risk of error was set at 5%.</p></sec><sec id="s3"><title>3. Results</title><p>Between 2015 and 2020, 5289 patients were admitted to the SMIT. We collected 55 cases of neuro-meningeal tuberculosis, representing a hospital frequency of 1.03% (<xref ref-type="table" rid="table1">Table 1</xref>) and an average of 9 cases per year. The median age was 38 years (range 16 - 77 years). The most affected age group was patients aged between 20 and 40 years (45.45%, n = 25) (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Patients were predominantly male (76.36) with a sex ratio (M/F) of 3.23. Most of patients (45.45%) live in suburban localities of Dakar. A history of contact was found in 14.5% of cases. HIV-infected patients represented 41.82%. A history of tuberculosis was found in 25.5% of cases (<xref ref-type="table" rid="table2">Table 2</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Annual incidence of neuro-meningeal tuberculosis at SMIT of Fann Hospital from 2015 to 2020</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Year</th><th align="center" valign="middle" >Admitted Patients</th><th align="center" valign="middle" >NMT Cases</th><th align="center" valign="middle" >Incidence (%)</th></tr></thead><tr><td align="center" valign="middle" >2015</td><td align="center" valign="middle" >1026</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.19</td></tr><tr><td align="center" valign="middle" >2016</td><td align="center" valign="middle" >991</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.8</td></tr><tr><td align="center" valign="middle" >2017</td><td align="center" valign="middle" >987</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >1.41</td></tr><tr><td align="center" valign="middle" >2018</td><td align="center" valign="middle" >937</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >1.92</td></tr><tr><td align="center" valign="middle" >2019</td><td align="center" valign="middle" >938</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.42</td></tr><tr><td align="center" valign="middle" >2020</td><td align="center" valign="middle" >410</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >2.19</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >5289</td><td align="center" valign="middle" >55</td><td align="center" valign="middle" >1.03</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Epidemiological characteristics of NMT at SMIT, Dakar (n = 55)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Epidemiological Characteristics</th><th align="center" valign="middle" >Frequency (n)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Sex</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >76.36</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >23.64</td></tr><tr><td align="center" valign="middle" >Origin</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Suburban</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >45.45</td></tr><tr><td align="center" valign="middle" >Urban</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >25.45</td></tr><tr><td align="center" valign="middle" >Rural</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >29.09</td></tr><tr><td align="center" valign="middle" >History of contact</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >08</td><td align="center" valign="middle" >14.55</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >47</td><td align="center" valign="middle" >85.45</td></tr><tr><td align="center" valign="middle" >HIV status</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >41.82</td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >58.18</td></tr><tr><td align="center" valign="middle" >History of TB</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >25.46</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >74.54</td></tr></tbody></table></table-wrap><p>The delay in consultation was greater than one month in 60% of patients. Headache was the most constant reason for consultation (94.55%), Neck stiffness was present for 94.55% of patients, fever was found in 69.09% of cases and vomiting in 60%. Physical examination revealed meningeal signs in 94.55% of cases, consciousness disorders and intracranial hypertension were noted in 63.64% and 56.36% respectively. Nerve palsy was found in 38.18% and pyramidal syndrome in 36.36% of cases. Behavioral disorders were presented in 29.09% (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>Lumbar puncture was performed in 89.09%. The CSF was clear in 81.64%. The mean cytology value was 312.69 &#177; 614.83/mm<sup>3</sup>. Thirty-five patients (71.4%) had 100% lymphocytic CSF. High protein level (&gt;1 g/L) was noted in 77.50%, and 71.40% had hypoglycorachia (&lt;0.5 g/L). GeneXpert MTB/RIF in CSF was performed in 33 patients and was positive in 4 patients (12.12%); no cases of rifampicin resistance were detected (<xref ref-type="table" rid="table4">Table 4</xref>). CRP was elevated at 85.45%, the mean value was 59.19 &#177; 58.55 mg/L.</p><p>Brain CT performed in 78.18%, was abnormal in 72.09% of cases. Tuberculoma (27.90%), hydrocephalus (16.27%) and meningeal contrast enhancement (11.62%) were the main lesions. The neuro-meningeal localization was isolated in 61.18%, and in 32.7% it was associated with a pulmonary TB. All patients had been put on anti-tuberculosis treatment (2RHZE/10RH), which had been initiated in 83.64% of cases within a week of hospitalization.</p><p>Hyponatremia was the most frequent complication (50.9%). The median hospital stay was 19 days [range 2 - 96 days], and the average length of hospital stay was 22.75 days &#177; 18.14 days. Twelve patients (21.8%) died during hospitalization. There was no association between HIV status and death (p = 0.8). The presence of seizures was not statistically significantly associated with death (p = 0.46). The Lethality rate was higher in women (46.2% vs. 14.3%; p = 0.01), in patients whose delay in consultation was &gt;1 month (p = 0.03), and in patients who presented consciousness disorders (p = 0.007). We did not find age, HIV status, or the presence of seizures as associated factors of death in our study (<xref ref-type="table" rid="table5">Table 5</xref>).</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Clinical characteristics of NMT at SMIT, Dakar (n = 55)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Clinical Characteristics</th><th align="center" valign="middle" >Frequency (n)</th><th align="center" valign="middle" >Percentage (%)</th><th align="center" valign="middle" ></th></tr></thead><tr><td align="center" valign="middle" >Delay in admission</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;1 month</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >40.00</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&gt;1 month</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >60.00</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Headache</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >94.55</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Neck stiffness</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >94.55</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Fever</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >69.09</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Consciousness disorder</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >63.64</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Vomiting</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >60.00</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Intracranial hypertension</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >56.36</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Nerve palsy</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >38.18</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Pyramidal syndrome</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >36.36</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Behavior disorder</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >29.09</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Cerebellar syndrome</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >21.82</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Seizures</td><td align="center" valign="middle" >10</td><td align="center" valign="middle"  colspan="2"  >18.18</td></tr><tr><td align="center" valign="middle" >Associated pulmonary TB</td><td align="center" valign="middle" >18</td><td align="center" valign="middle"  colspan="2"  >32.72</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> CSF cytochemistry study in neuro-meningeal tuberculosis cases at SMIT, Fann Hospital (n = 49)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >CSF Cytochemistry</th><th align="center" valign="middle" >Frequency (n)</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Macroscopic CSF appearance</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Clear</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >81.64</td></tr><tr><td align="center" valign="middle" >Purulent</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >18.36</td></tr><tr><td align="center" valign="middle" >Pleiocytosis/mm<sup>3</sup></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;5</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >22.45</td></tr><tr><td align="center" valign="middle" >[5 - 300[</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >46.90</td></tr><tr><td align="center" valign="middle" >&gt;300</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >30.61</td></tr><tr><td align="center" valign="middle" >Predominance</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Lymphocytes</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >71.40</td></tr><tr><td align="center" valign="middle" >Neutrophiles</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >4.00</td></tr><tr><td align="center" valign="middle" >variegated</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >24.60</td></tr><tr><td align="center" valign="middle" >Proteinorachia</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;1 g/l</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >22.50</td></tr><tr><td align="center" valign="middle" >≥1 g/l</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >77.50</td></tr><tr><td align="center" valign="middle" >Glycorachia</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;0.5 g/l</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >71.40</td></tr><tr><td align="center" valign="middle" >≥0.5 g/l</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >28.60</td></tr><tr><td align="center" valign="middle" >LCS GeneXpert MTB/RIF (n = 33)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >12.12</td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >87.88</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Associated factors with death in neuro-meningeal tuberculosis cases at SMIT, Fann hospital (n = 55)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Associated Factors</th><th align="center" valign="middle"  colspan="2"  >Death</th><th align="center" valign="middle"  rowspan="2"  >p</th></tr></thead><tr><td align="center" valign="middle" >Yes, n (%)</td><td align="center" valign="middle" >No, n (%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Sex</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >6 (14.3)</td><td align="center" valign="middle" >36 (85.7)</td><td align="center" valign="middle"  rowspan="2"  >0.01</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >6 (46.2)</td><td align="center" valign="middle" >7 (53.8)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >HIV status</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >5 (21.7)</td><td align="center" valign="middle" >18 (78.3)</td><td align="center" valign="middle"  rowspan="2"  >0.8</td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >7 (22.6)</td><td align="center" valign="middle" >24 (77.4)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Delay in admission</td><td align="center" valign="middle" >&gt;1 month</td><td align="center" valign="middle" >10(30.3)</td><td align="center" valign="middle" >23 (69.7)</td><td align="center" valign="middle"  rowspan="2"  >0.03</td></tr><tr><td align="center" valign="middle" >&lt;1 month</td><td align="center" valign="middle" >2 (9.1)</td><td align="center" valign="middle" >20 (90.9)</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Glasgow score</td><td align="center" valign="middle" >[5 - 9[</td><td align="center" valign="middle" >1 (20.0)</td><td align="center" valign="middle" >4 (80.0)</td><td align="center" valign="middle"  rowspan="3"  >0.007</td></tr><tr><td align="center" valign="middle" >[9 - 13[</td><td align="center" valign="middle" >6 (46.2)</td><td align="center" valign="middle" >7 (53.8)</td></tr><tr><td align="center" valign="middle" >[13 - 14[</td><td align="center" valign="middle" >0 (0.0)</td><td align="center" valign="middle" >17 (100)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Seizures</td><td align="center" valign="middle" >yes</td><td align="center" valign="middle" >2 (20.0)</td><td align="center" valign="middle" >8 (80.0)</td><td align="center" valign="middle"  rowspan="2"  >0.46</td></tr><tr><td align="center" valign="middle" >no</td><td align="center" valign="middle" >10 (22.2)</td><td align="center" valign="middle" >35 (77.8)</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussion</title><p>In our study, we found a hospital frequency of 1.03% and an annual incidence of 9.16 cases per year. Incidences of neuro-meningeal tuberculosis vary from one series to another [<xref ref-type="bibr" rid="scirp.126778-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.126778-ref6">6</xref>] . This variability can be explained by the difference between the type of population studied, the conditions under which it was carried out, the study sites and the diagnostic tools used.</p><p>Patients were mainly young in our study. These data are similar to those observed in Africa [<xref ref-type="bibr" rid="scirp.126778-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.126778-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.126778-ref9">9</xref>] . Indeed, this age group corresponds to the active population, which is the most representative in our countries. The distribution of neuro-meningeal tuberculosis by sex varied according to the different series in the literature. The strong male predominance observed in our study confirms the data in the literature in which male predominance remains classic [<xref ref-type="bibr" rid="scirp.126778-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.126778-ref6">6</xref>] . However, Ossibibi in Congo in 2020 [<xref ref-type="bibr" rid="scirp.126778-ref6">6</xref>] reported a female predominance (67.9%), while Dollo and al., found in Casablanca in 2017, an equal distribution between men and women [<xref ref-type="bibr" rid="scirp.126778-ref7">7</xref>] .</p><p>A low rate of contact history was found by several authors [<xref ref-type="bibr" rid="scirp.126778-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.126778-ref9">9</xref>] , like our result, while the prevalence of the disease is high in our regions, this situation could be explained by ignorance of the disease by most of the population, the importance of undiagnosed cases making it difficult to assess the notion of contact. A history of TB was found in 25.4% of cases, this result was like the data found in the literature, according to which a history of tuberculosis is frequently found in subjects with meningitis tuberculosis [<xref ref-type="bibr" rid="scirp.126778-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.126778-ref10">10</xref>] .</p><p>The frequency of the association of tuberculosis and HIV infection was found in our study (41.82%), as reported by all authors, particularly the neuro-meningeal localization [<xref ref-type="bibr" rid="scirp.126778-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.126778-ref7">7</xref>] .</p><p>The lengthy consultation periods in this study are similar to those described by several African authors [<xref ref-type="bibr" rid="scirp.126778-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.126778-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.126778-ref11">11</xref>] . The long delay in consultation may be due to several factors, particularly the clinical polymorphism of the disease, the delay in suspicion of tuberculosis by clinicians, the lack of medical information or the difficulties of access to local medical services in our context.</p><p>The main symptoms found at admission headache were fever and consciousness disorder. These data have also been found by several authors [<xref ref-type="bibr" rid="scirp.126778-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.126778-ref12">12</xref>] . Cranial nerve palsy remains a frequent manifestation of neuro-meningeal tuberculosis and was found in 38.18% of cases in our study. Similar results were found by Amara et al. [<xref ref-type="bibr" rid="scirp.126778-ref13">13</xref>] . The extra-neurological locations were common in our cases. They were pulmonary in most of the cases. These results are consistent with those obtained by several authors [<xref ref-type="bibr" rid="scirp.126778-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.126778-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.126778-ref9">9</xref>] .</p><p>NMT is one of meningitis with clear or lymphocyte fluid as reported in our study to significant proportions. The local inflammatory reaction at the meningeal level reflects the hyperproteinorachie found. These results corroborate the data mentioned in the literature by several African authors [<xref ref-type="bibr" rid="scirp.126778-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.126778-ref7">7</xref>] .</p><p>GeneXpert MTB/rif in CSF was positive in 12.12%. The detection of Mycobacterium tuberculosis by microscopic examination of CSF is an important means of confirming the diagnosis, but its sensitivity remains low. Thus, the diagnosis of TNM remains difficult and in most cases relies on a range of arguments. This situation tends to delay the diagnosis and exposes patients to the occurrence of complications, which worsens the prognosis of the disease. Brain CT is an important diagnostic tool; however, abnormalities are highly variable. The incidence of hydrocephalus increases with the duration of the disease and decreases with age. It is particularly frequent in children, found in 87% of cases, whereas it is observed in only 12% of adults [<xref ref-type="bibr" rid="scirp.126778-ref14">14</xref>] .</p><p>Hyponatremia, the most frequent systemic complication, was found in our series. This biological abnormality is responsible for consciousness disorders [<xref ref-type="bibr" rid="scirp.126778-ref15">15</xref>] . The long delay in diagnosis is an associated factor in many series [<xref ref-type="bibr" rid="scirp.126778-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.126778-ref6">6</xref>] , as found in our study. Moreover, we found lethality higher in women (46.2% vs. 14.3%; p = 0.01) without explanation.</p><p>The SMIT of Fann University Hospital has been equipped with an archival unit for efficient data management. But this asset did not prevent from finding out certain files with missing information. However, this study has shed light on the epidemiological situation of neuro-meningeal tuberculosis at the Fann University Hospital while notifying the share of HIV infection in a country with limited resources.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Tuberculosis remains a public health problem and neuro-meningeal involvement represents one of the most severe forms. Its highly variable clinical expression and the low sensitivity of the GeneXpert MTB/RIF in the CSF often make diagnosis difficult, thus exposing patients to serious complications. Among the factors associated with death, we find consciousness disorders and long delays in diagnosis.</p></sec><sec id="s6"><title>Consent</title><p>The patients had signed an informed consent form, which is available.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>We have no conflicts of interest.</p></sec><sec id="s8"><title>Authors’ Contributions</title><p>Daouda Thioub, and Papa Latyr Junior Diouf wrote the manuscript with input of Agbogbenkou Tevi D&#233;la-dem Lawson and Viviane Marie Pierre Cisse Diallo.</p><p>Ndeye Aissatou Lakhe and Ndeye Fatou Ngom Gueye drafted the manuscript for important intellectual content. Moussa SEYDI and Sylvie Audrey Diop drafted and approved the final version to be published.</p></sec><sec id="s9"><title>Funding Statement</title><p>This manuscript did not receive a grant.</p></sec><sec id="s10"><title>Cite this paper</title><p>Thioub, D., Cisse-Diallo, V.M.P., Diouf, P.L.J., Lakhe, N.A., Lawson, A.T., Badiane, A.S., Fall, N.M., Diallo-Mbaye, K., Ka, D., Diop, S.A. and Seydi, M. (2023) Neuro-meningeal Tuberculosis in Adult Senegalese Patients: Profile and Outcome of Cases Diagnosed at a Referral Service, from 2015 to 2020. Case Reports in Clinical Medicine, 12, 270-278. https://doi.org/10.4236/crcm.2023.128038</p></sec></body><back><ref-list><title>References</title><ref id="scirp.126778-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Ait Khaled, N. and Enarson, D. (1999) Tuberculose: Manuel pour les étudiants. OMS-Union Internationale contre la tuberculose et les maladies respiratoires. WHO/CDC/TB, 192.</mixed-citation></ref><ref id="scirp.126778-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Misra, U.K., Kalita, J., Bhoi, S.K. and Singh, R.K. (2016) A Study of Hyponatremia in Tuberculous Meningitis. Journal of the Neurological Sciences, 367, 152-157. https://doi.org/10.1016/j.jns.2016.06.004</mixed-citation></ref><ref id="scirp.126778-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Cresswell, F.V., Tugume, L., Bahr, N.C., Kwizera, R., Bangdiwala, A.S., Musubire, A.K., et al. (2020) Xpert MTB/ RIF Ultra for the Diagnosis of HIV-Associated Tuberculous Meningitis: A Prospective Validation Study. The Lancet Infectious Diseases, 20, 308-317. https://doi.org/10.1016/S1473-3099(19)30550-X</mixed-citation></ref><ref id="scirp.126778-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Thwaites, G.E., Bang, N.D., Dung, N.H., et al. (2004) Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and Adults. The New England Journal of Medicine, 351, 1741-1751. https://doi.org/10.1056/NEJMoa040573</mixed-citation></ref><ref id="scirp.126778-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Soria, J., Metcalf, T., Mori, N., et al. (2019) Mortality in Hospitalized Patients with Tuberculous Meningitis. BMC Infectious Diseases, 19, Article No. 9. https://doi.org/10.1186/s12879-018-3633-4</mixed-citation></ref><ref id="scirp.126778-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Ossibi Ibara, B.R., Ekat, M., Atipo-Tsiba, P.W., et al. (2020) Neuromeningeal Tuberculosis at the Brazzaville University Hospital: Prevalence and Associated Factors. Microbiology &amp; Infectious Diseases, 4, 1-5.</mixed-citation></ref><ref id="scirp.126778-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Dollo, I., El Fane, M., Es-Sebbani, M., et al. (2017) Méningite tuberculeuse confirmée: à propos de 52 cas. Pratique Neurologique—FMC, 8, 168-173. https://doi.org/10.1016/j.praneu.2017.06.011</mixed-citation></ref><ref id="scirp.126778-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Guenifi, W., Gasmi, A., Boukhrissa, H., et al. (2018) Cerebro-Meningeal Tuberculosis in HIV-Negative Adults. Journal of Infectious Diseases and Epidemiology, 4, 55. https://doi.org/10.23937/2474-3658/1510055</mixed-citation></ref><ref id="scirp.126778-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Christensen, A.-S.H., Andersen, A.B., Thomsen, V.O., et al. (2011) Tuberculous Meningitis in Denmark: A Review of 50 Cases. BMC Infectious Diseases, 11, Article No. 47. https://doi.org/10.1186/1471-2334-11-47</mixed-citation></ref><ref id="scirp.126778-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Zayet, S., Berriche, A., Abdelmalek, R., et al. (2017) La tuberculose neuro-méningée: une série hospitalière de 157 cas. Médecine et Maladies Infectieuses, 47, S103. https://doi.org/10.1016/j.medmal.2017.03.252</mixed-citation></ref><ref id="scirp.126778-ref11"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Koffi</surname><given-names> A. and Kouassi </given-names></name>,<etal>et al</etal>. (<year>2004</year>)<article-title>Analyse des critères diagnostiques de la tuberculose de l’enfant en milieu ivoirien hospitalier</article-title><source> Bulletin de la Société de Pathologie Exotique</source><volume> 97</volume>,<fpage> 127</fpage>-<lpage>128</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.126778-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Kilani, B., Ammari, L., Tiouiri, H., et al. (2003) Manifestations neuroradiologiques initiales de la tuberculose du système nerveux central de l’adulte. à propos de 122 cas. La Revue de Médecine Interne, 24, 86-96. https://doi.org/10.1016/S0248-8663(02)00716-6</mixed-citation></ref><ref id="scirp.126778-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Amara, N., Marrakchi, C., Koubaa, M., Hammami, B., Maaloul, I. and Benjemaa, M. (2017) Particularités épidémio-cliniques, diagnostiques et évolutives de la tuberculose neuro-méningée. Revue Neurologique, 173, S161. https://doi.org/10.1016/j.neurol.2017.01.303</mixed-citation></ref><ref id="scirp.126778-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Kaya, J.M., Alliez, J.R. and Bou-Harb, G. (2001) Abcès tuberculeux du cervelet: à propos d’un cas. Neurochirurgie, 47, 568-571.</mixed-citation></ref><ref id="scirp.126778-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Mai, N.T. and Thwaites, G.E. (2017) Recent Advances in the Diagnosis and Management of Tuberculous Meningitis. Current Opinion in Infectious Diseases, 30, 123-128. https://doi.org/10.1097/QCO.0000000000000331</mixed-citation></ref></ref-list></back></article>